In this study, we found that overexpression of SFRP2 in the prostate cancer cell line PC3 increases the expression of osteoblast-like genes, when seeded on the most abundant bone extracellular matrix (ECM) structural protein, collagen 1 (COL1). The gene discussed is SFRP2; the disease is prostate carcinoma.